NIH-funded research R01 grant

Gentle electrical brain stimulation to help word-finding in primary progressive aphasia

Official title: Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia

Funded at University of Pennsylvania · NIH-11124741 · Data updated 2026-11-12

This project combines gentle electrical brain stimulation with speech exercises to help people with primary progressive aphasia (PPA) find words more easily.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 30, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$1,075,653
NIH project number5R01AG075111-04
Project IDNIH-11124741 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with primary progressive aphasia who experience word-finding difficulties and meet the study's eligibility requirements are ideal candidates.

Less likely to help

People without PPA, those whose language problems stem from other causes, or those with medical issues that prevent safe brain stimulation (for example implanted electronic devices or uncontrolled seizures) may not be eligible or benefit.

What this research studies

You would take part at one of three specialist centers where you'll receive transcranial direct current stimulation (tDCS) — a gentle, noninvasive electrical stimulation to the scalp — while doing language tasks aimed at improving anomia. The trial is randomized, double-blind, and uses a within-subject crossover design so participants receive both active and sham sessions at different times without knowing which is which. About 120 people with PPA will be enrolled across sites (University of Pennsylvania, Johns Hopkins, and Baycrest) to provide stronger evidence than prior small studies. Researchers will track changes in word-finding and everyday communication over the treatment period.

Why it matters

Potential benefit: If successful, this approach could improve word-finding and daily communication for people with PPA.

How similar studies have gone: Small prior studies of tDCS in PPA have suggested possible benefits but were limited in size, and this is the first well-powered multi-site Phase 2 trial to test the therapy more rigorously.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hamilton, Roy H — University of Pennsylvania
  • Study coordinator: Hamilton, Roy H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.